INS and cancer: In conclusion, we have developed a model for evaluating the effect of administered insulins on the growth of pre-existing cancers in insulin resistant animals and demonstrated that supra-pharmacological doses of insulin analog X10 and human IGF-1, hypothesized to be positive control compounds, increase growth of MC38 cell allografts in short-term animal experiments.